Related Experiment Video
Updated: May 10, 2026

In Vitro Chemical Mapping of G-Quadruplex DNA Structures by Bis-3-Chloropiperidines
Published on: May 12, 2023
Pentose phosphate pathway function affects tolerance to the G-quadruplex binder TMPyP4
Elizabeth J Andrew1, Stephanie Merchan, Conor Lawless
1Institute for Cell and Molecular Biosciences, Newcastle University Medical School, Newcastle Upon Tyne, United Kingdom.
Abstract:
G-quadruplexes form in guanine-rich regions of DNA and the presence of these structures at telomeres prevents the activity of telomerase in vitro. Ligands such as the cationic porphyrin TMPyP4 stabilise G-quadruplexes and are therefore under investigation for their potential use as anti-cancer drugs. In order to investigate the mechanism of action of TMPyP4 in vivo, we carried out a genome-wide screen in the budding yeast Saccharomyces cerevisiae. We found that deletion of key pentose phosphate pathway (PPP) genes increased the sensitivity of yeast to the presence of TMPyP4. The PPP plays an important role in the oxidative stress response and sensitivity to TMPyP4 also increased when genes involved in the oxidative stress response, CCS1 and YAP1, were deleted. For comparison we also report genome wide-screens using hydrogen peroxide, which causes oxidative stress, RHPS4, another G-quadruplex binder and hydroxyurea, an S phase poison. We found that a number of TMPyP4-sensitive strains are also sensitive to hydrogen peroxide in a genome-wide screen. Overall our results suggest that treatment with TMPyP4 results in light-dependent oxidative stress response in budding yeast, and that this, rather than G-quadruplex binding, is the major route to cytotoxicity. Our results have implications for the usefulness and mechanism of action of TMPyP4.
Insights
The anti-cancer drug candidate TMPyP4 causes light-dependent oxidative stress in yeast, not G-quadruplex binding. This finding impacts the drug
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- G-quadruplexes are DNA structures found in guanine-rich regions, particularly at telomeres.
- Ligands like TMPyP4 stabilize G-quadruplexes and are investigated as anti-cancer agents.
- Understanding TMPyP4's in vivo mechanism is crucial for its therapeutic potential.
Purpose of the Study:
- To elucidate the in vivo mechanism of action of the G-quadruplex ligand TMPyP4.
- To identify cellular pathways involved in TMPyP4 sensitivity using a genome-wide screen in Saccharomyces cerevisiae.
Main Methods:
- Conducted a genome-wide screen in budding yeast (Saccharomyces cerevisiae) to identify genes affecting TMPyP4 sensitivity.
- Assessed sensitivity to TMPyP4, hydrogen peroxide, RHPS4, and hydroxyurea in gene deletion strains.
- Investigated the role of the pentose phosphate pathway (PPP) and oxidative stress response genes (CCS1, YAP1).
Main Results:
- Deletion of key pentose phosphate pathway (PPP) genes increased yeast sensitivity to TMPyP4.
- Sensitivity to TMPyP4 was also elevated in strains lacking oxidative stress response genes (CCS1, YAP1).
- TMPyP4-sensitive strains showed cross-sensitivity to hydrogen peroxide, suggesting a role for oxidative stress.
Conclusions:
- TMPyP4 treatment induces a light-dependent oxidative stress response in budding yeast.
- Oxidative stress, rather than direct G-quadruplex binding, appears to be the primary mechanism of TMPyP4 cytotoxicity.
- Findings have significant implications for the therapeutic application and understanding of TMPyP4's mechanism of action.
Related Concept Videos
Biosynthesis of Nucleic Acids
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Proofreading
Proofreading
Errors During Replication are Corrected by the DNA Polymerase Enzyme

